ALB vs APVO · rev $1.74B vs $9.9M cap
Albemarle Corp (ALB) versus Aptevo Therapeutics Inc (APVO) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
APVO does not have a complete income-statement cache yet.
ALB currently screens at market cap $8.00B. APVO currently screens at market cap $9.9M.
Not investment advice. Open the ALB and APVO stock pages for the full models.
Not investment advice.